RYTHM, Inc. (RYM) 주식 분석

회사 개요

RYTHM, Inc. operates within the United States market by providing specialized solutions for the cannabis and hemp sectors, offering consumers hemp-derived tetrahydrocannabinol beverages alongside a variety of other hemp-derived products available through retail partnerships and direct-to-retail channels. The company is categorized under the Consumer Defensive sector, specifically within the Tobacco industry, a classification that reflects the regulatory environment and consumer spending patterns associated with these goods despite the distinct nature of its hemp-based product lines. Currently, RYTHM, Inc. holds a market capitalization of $51.54M and generates annual revenue of $17.28M, employing a workforce of 1 individual according to the available corporate data. These financial figures indicate that the company operates on a small-cap scale with limited operational breadth, as evidenced by the single employee count which suggests a highly specialized or early-stage business model focused on niche product distribution rather than broad-scale manufacturing. The disparity between the $51.54M valuation and the $17.28M revenue stream highlights a market premium that investors are assigning to the company's specific foothold in the emerging hemp beverage market, implying significant expectations for future scalability despite the current lack of a large workforce.

재무 건전성

The company reported a revenue of $17.28M over the trailing twelve months, yet this figure stands in stark contrast to a net income of $-34,740,000 and an EBITDA of $-16,822,000, revealing a substantial gap that points to a highly aggressive or inefficient cost structure where expenses significantly outweigh earnings before interest, taxes, and depreciation. Free cash flow stands at $-21,676,124, indicating that the company is currently burning cash rather than generating liquidity, which severely limits its financial flexibility and ability to fund operations or pursue capital-intensive expansion without external financing. While the gross margin remains positive at 59.0%, the operating margin is negative at -33.7% and the profit margin is severely depressed at -192.4%, suggesting that while the core product sales retain value, high overhead costs or one-time expenses are eroding profitability at an unsustainable rate. The balance sheet shows a cash position of $32.22M against total debt of $80.62M, resulting in a debt-to-equity ratio of 619.21, which signifies a highly leveraged capital structure where debt obligations vastly exceed equity holdings. Despite the heavy debt load, the current ratio of 1.11 indicates that the company maintains just enough liquid assets to cover its short-term liabilities, though this provides a narrow margin of safety against liquidity shocks. Return on Equity is calculated at -169.0% and Return on Assets at -17.9%, metrics that clearly demonstrate management's current ineffectiveness in generating positive returns on the capital invested by shareholders and creditors.

밸류에이션 평가

Both the P/E Ratio (TTM) and the Forward P/E are listed as N/A, which mathematically implies that there are no expected earnings in the near future to justify a traditional earnings-based valuation, leaving the difference between these metrics nonexistent due to the absence of profitable performance. The price-to-book ratio stands at 3.96, indicating that the market values the company at nearly four times its net asset book value, a significant premium that suggests investors are pricing in high growth potential despite the current lack of profitability. Alternative valuation metrics further complicate the picture, with a price-to-sales ratio of 2.98 and an EV/EBITDA of -5.94, suggesting that the stock is valued based on revenue generation rather than earnings power, while the negative EV/EBITDA confirms the company is not yet generating enough cash flow to cover its enterprise value through earnings. The stock has traded between a 52-week high of $53.65 and a 52-week low of $13.22, illustrating a massive intrayear volatility range where the current price position relative to this span reflects extreme sensitivity to market sentiment regarding the cannabis sector. The beta value of 9.82 is exceptionally high compared to the broader market, indicating that the stock's price volatility is nearly ten times that of the general market, making it a highly speculative asset for investors seeking exposure to the hemp industry.

Growth & Income

The available facts list Revenue Growth (YoY) and Earnings Growth (YoY) as N/A, meaning there is no historical data provided to determine whether earnings are growing faster or slower than revenue, preventing any definitive analysis of the company's growth trajectory based on past performance. As a non-dividend payer, the company does not distribute a dividend yield or a payout ratio, instead retaining all earnings which are currently negative to reinvest into growth initiatives or to service its substantial debt obligations. The absence of a dividend yield of 0.0% and a payout ratio of 0.0% confirms that the company prioritizes capital retention over income distribution, a common strategy for small-cap firms in developmental stages that require cash for operations rather than shareholder payouts. Summarizing the overall profile, RYTHM, Inc. presents a high-risk, high-volatility growth stock with no current income generation, relying entirely on the potential future expansion of its hemp-derived product portfolio to turn its current negative cash flows into sustainable profits.